RE:The next indicationOilminerDeluxe after 5+ years invested in TLT i have learned that timelines should be properly called " optimistic guesses " . In the world of junior biotechs , being entangled in govt bureaucracy is part of life . Now this chinese virus will affect certain aspects of our corporation ( yes . ours , we are shareholders } but it will not affect the patients Ph2 trial results and that is what should/will move the PPS . As for the next indication{s} , your guess is as good as anybody except the people in charge of TLT and they were somewhat vague ...when Ph2 is well underway.
Cheers
Oilminerdeluxe wrote: Does the board think this virus mess and what will follow in the aftermath, possible sharp recessions, fear of new outbreaks, etc etc, will delay the next indication(s) to take place in an acceptable time frame? To me, they have had plenty of time to work with that ORF money. Many scientific stuff to tell them where they sit. I do not know how expensive such trials will be if going alone, but I can't say I think they will be too expensive. Not in a "normal" climate. But we are not in a normal climate, sadly. Is this a concern that further trials will be affected if the virus thing continues for months and months? I can imagine if they spit out good results from Phase II that a money raise won't be a problem, if needed, but in this freaking environment, I bet we can go 5 for 5 and not move us past 30 cents. That's how broken we are. Any way, perhaps a nonsense post, but at least it's about Theralase...